Science & Research

NAD+ infusion therapy is being marketed aggressively for addiction recovery, withdrawal management, and "brain restoration." This evidence-based review examines what NAD+ is, what the science actually supports, where the evidence is lacking, and how it might appropriately fit into addiction care.

Clinical research is producing a new generation of addiction treatments that target the condition with unprecedented precision. From psychedelic-assisted therapy and advanced neuromodulation to anti-drug vaccines and gene therapies, the future of addiction treatment is rapidly evolving.

Ibogaine, a psychoactive alkaloid derived from the West African iboga plant, has attracted intense research interest for its apparent ability to rapidly interrupt opioid withdrawal and reduce craving. This detailed review examines what the evidence shows, the significant cardiac risks, and the current state of clinical research.

The prefrontal cortex governs the decision-making, impulse control, and future planning that addiction systematically impairs. Understanding how the PFC is compromised by substance use — and how it recovers — illuminates both the compulsive nature of addiction and the path to genuine, lasting behavioral change.

Longitudinal studies that follow individuals with substance use disorders over years to decades have provided invaluable insights into the natural history of addiction and recovery that shorter studies cannot capture. This review examines what long-term research reveals about recovery trajectories, how the probability of sustained recovery changes with time, and what factors most powerfully shape long-term outcomes.

The dopamine system is central to understanding addiction, but popular misconceptions often oversimplify its role. This comprehensive guide examines how dopamine signaling is altered in addiction, the concept of reward prediction error, and how evidence-based treatments restore dopaminergic function.

Biomarkers, objective biological measures that reflect disease state or treatment response, are increasingly being investigated in addiction medicine as tools for personalizing treatment selection and monitoring recovery. This review examines the current state of biomarker research in addiction, from established biological markers to emerging neuroimaging and genetic biomarkers with potential clinical applications.

Anti-drug vaccines represent a biologically elegant approach to addiction treatment: training the immune system to produce antibodies that bind drug molecules and prevent them from crossing the blood-brain barrier. This evidence review explains the science, clinical trial results, and significant remaining challenges.

Hedonic adaptation explains why substances produce diminishing pleasure over time while ordinary life feels increasingly gray. Understanding this mechanism is key to rebuilding a satisfying, drug-free life in recovery — and to understanding why recovery genuinely gets better with time.

The brain possesses a remarkable capacity for self-repair through neuroplasticity. This article explores the science behind neural recovery from addiction, including timeline expectations, evidence-based strategies that promote healing, and how treatment programs leverage neuroplasticity for lasting recovery.

Addiction is not nature or nurture but the interaction between them. Gene-environment interaction research reveals how specific genetic variants modify the impact of life experiences on addiction risk.

Epigenetics, the study of heritable changes in gene expression that do not involve alterations to the DNA sequence itself, is emerging as one of the most exciting frontiers in addiction science. Research reveals how chronic substance use produces lasting changes in gene regulation that drive compulsive behavior, how stress and trauma alter addiction vulnerability through epigenetic mechanisms, and how these changes may be transmitted across generations.

Cross-addiction — the development of a new addictive pattern after achieving sobriety from the primary substance — is a neurobiologically documented clinical phenomenon. Understanding the shared reward circuit mechanisms that create this vulnerability is essential for comprehensive, lasting recovery.

Virtual reality technology is finding clinical applications in addiction treatment, from cue exposure and extinction training to social skills practice and relapse scenario rehearsal. This evidence review explores what VR therapy can and cannot offer in addiction care.

Addiction often follows multigenerational patterns within families. Understanding the mechanisms, from genetic transmission to cultural modeling, is essential for developing strategies to break these cycles.

How virtual reality exposure therapy creates immersive, controlled environments where individuals practice cue resistance and craving management skills under therapeutic supervision.

Research estimates that genetic factors account for 40-60% of addiction vulnerability. This article explores the specific genes, epigenetic mechanisms, and gene-environment interactions that shape individual risk for substance use disorders.

Moving beyond the harm reduction versus abstinence debate to evidence-based integration. How combining both approaches across the recovery continuum produces superior outcomes for diverse populations.

How digital phenotyping passively analyzes smartphone usage patterns, GPS mobility, communication frequency, and typing dynamics to identify behavioral biomarkers of relapse risk.

How wearable biosensors monitoring heart rate variability, skin conductance, and movement patterns enable real-time detection of relapse risk and automated intervention delivery.

How artificial intelligence and machine learning algorithms are transforming addiction screening, enabling earlier detection and more accurate relapse prediction than traditional clinical assessment.

How modifications to the Ryan Haight Act transformed telehealth prescribing of controlled substances for addiction treatment, expanding medication-assisted treatment access during and after the pandemic.

How digital peer support platforms extend recovery community access beyond meeting rooms, providing 24/7 connection with peers, mentors, and mutual aid networks through smartphone applications.

As direct-to-consumer genetic testing grows more accessible, addiction risk assessments are increasingly marketed to consumers. This article provides a critical evaluation of what these tests can actually predict.